SUPER LEAGUE ENTERPRISE INC
SLENASDAQTrading Snapshot
- Day Range
- $5.48 β $5.55
- 52-Week Range
- $2.12 β $71.88
- Volume
- $1.84B
- Avg Volume
- $1.87B
- Shares Outstanding
- 1.5M
- Next Earnings
- Nov 20, 2026
Fundamentals Snapshot
- Annual Revenue
- $11M
- Last Q Revenue
- $3M
- P/E Ratio
- β
- P/S Ratio
- 1.2x
- EPS (TTM)
- $-37.08
- Dividend Yield
- β
- Dilution (1yr)
- +415.4%
Why Investors Own SLE
- βHigh-growth profile β revenue up +23.0% YoY with expanding US Equity exposure.
- βHealthy economics β 71% gross margin and 30% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SUPER LEAGUE ENTERPRISE INC
SLEAbout SUPER LEAGUE ENTERPRISE INC
Super League Enterprise, Inc. (SLE) creates and oversees a comprehensive digital ecosystem within the metaverse gaming sphere. This ecosystem encompasses various games, sophisticated tools for monetization, and diverse content channels, all aimed at empowering game developers, energizing players, and entertaining fans. The company's offerings provide unparalleled access to a wide-ranging audience. This includes active participants within different metaverse environments, dedicated followers of gaming influencers, and viewers of gameplay content across popular social media and digital video platforms. SLE's advanced platform integrates access to vibrant in-game communities and a specialized advertising system designed for the metaverse. It also features a substantial network of highly-viewed channels and original programs distributed across major platforms such as Instagram, TikTok, Snapchat, YouTube, and Twitch. Furthermore, the platform incorporates cloud-based livestream production tools and hosts an exclusive esports invitational tournament series. These assets also offer significant opportunities for brands and advertisers to gather valuable insights and achieve their marketing goals by engaging with gamers of all ages. Established in 2014 and based in Santa Monica, California, the company was previously known as Super League Gaming, Inc. before officially changing its name to Super League Enterprise, Inc. in September 2023.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

New Super League White Paper Sizes Up the Web's Most Overlooked Ad-Friendly Audience: 100M+ Browser-Based Gamers
SANTA MONICA, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE), an audience intelligence and media activation company trusted by global brands to reach and influence people who play video games acros

Metaplanet to Invest 2,100 Bitcoin in Super League to Launch U.S. Bitcoin Treasury Platform, Superplanet
Super League to be renamed βSuperplanet, Inc.β and become Metaplanet's U.S. Bitcoin treasury platform, backed by the world's third-largest corporate Bitcoin holder with 43,000 BTC

Super League Enterprise, Inc. (SLE) Q2 2026 Earnings Call Transcript
Super League Enterprise, Inc. (SLE) Q2 2026 Earnings Call Transcript

Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance
Net Revenue increases 16% sequentially as gross margin expands five percentage points to 41%Β Adjusted EBITDA improves approximately 20% year-over-year as Company maintains disciplined cost structure SANTA MONICA, Calif.

Super League Sets Second Quarter 2026 Earnings Date, August 14, 2026
SANTA MONICA, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the βCompanyβ), an audience intelligence and media activation company trusted by global brands to reach and influence people who play vi

Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced the initiation of PRESERVE, a Phase 4, multicenter study investigating the combination of LUPKYNISΓ